Diffuse coronary artery disease is a subtype of coronary artery disease (CAD) in which larger sections of coronary arteries have a high plaque buildup. It is less common than focal CAD and can be more ...

Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of ...

Hereditary cancer syndromes are disorders that increase your risk of certain cancers due to mutations in one or more genes inherited from your parents. Genetic testing can help you determine your risk ...

Modeyso is the first FDA-approved systemic therapy for H3 K27M-mutant diffuse midline glioma, targeting both adult and pediatric patients. Clinical trials demonstrated a 22% overall response rate with ...

Modeyso is the first FDA-approved treatment for recurrent H3 K27M-mutant diffuse midline glioma, offering a new option for patients with limited choices. Phase II trials showed a 22% objective ...